Unilever PLC

UL · Consumer Defensive · Household & Personal Products · Valued as of 2026-11-03 · Statements 2025-12-31

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

What it is worth

EPV + Growth

120.73B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

82.23B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

88.73B USD

15 years of cash for shareholders and lenders, less what is owed

Average Intrinsic Value

97.23B USD

The plain average of EPV, Profit and FCFF

Against the price

Market Cap

128.44B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.76×

the ratio the screener ranks by

Margin of Safety

-32.1%

1 − Market Cap / Average Intrinsic Value

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

Earnings power value plus growth: 120.73B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)114.01B USD
+②Net Cash Today6.71B USD
+③Growth Value0 USD
=Value120.73B USD

EPV of the Operations (NOPAT over WACC)

114.01B USD

Net cash today

+6.71B USD

Growth Value

0 USD

Value

120.73B USD

①EPV (Earnings Power Value)

114.01B USD

②Net Cash Today

6.71B USD

③Growth Value

0 USD

Market value

Market Cap128.44B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-6.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 82.23B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE65.79B USD
+②Equity at Year 15, Today16.44B USD
=Value82.23B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

65.79B USD

②Equity at Year 15, Today

16.44B USD

Market value

Market Cap128.44B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-56.2%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 88.73B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF69.39B USD
+②Invested Capital at Year 15, Today12.63B USD
+③Net Cash Today6.71B USD
=Value88.73B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

69.39B USD

②Invested Capital at Year 15, Today

12.63B USD

③Net Cash Today

6.71B USD

Market value

Market Cap128.44B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-44.7%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 7.22%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.45×Market Risk Premium 6.00%= 7.22%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 2.92B USDPretax Income 10.22B USD= 28.54%

The tax the interest saves.

Interest Expense =EBIT 11,513.28M USD−Pretax Income 10,222.13M USD= —

The interest the company paid: EBIT is the profit before tax plus the interest.

No interest is read: it needs debt and an EBIT above the profit before tax, the gap between them being the interest. Without it the cost of debt takes the 4% default.

Cost of Debt 4.00% (default): with no debt or no interest read, the 4% default after tax stands for what the lenders are paid a year.

Debt Weight =Total Debt 0 USDMarket Cap + Total Debt 128.44B USD + 0 USD= 0.00%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 100.00%×Cost of Equity 7.22%+Debt Weight 0.00%×Cost of Debt 4.00%= 7.22%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 87.96B USD − Total Liabilities 67.03B USD = Book Value Today 20.93B USD

Total Debt 0 USD − Cash and Short-Term Investments 6.71B USD = Net Debt Today -6.71B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-3.1%at most 5%passes2,153,300,000 / 2,221,349,183
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets-1.5%at least -10.0%passes(9.82B USD − 11.13B USD) ÷ 87.96B USD
Price to bookMarket Cap ÷ Book Value Today6.14×at most 3×does not pass128.44B USD ÷ 20.93B USD
Operating marginOperating Income ÷ Revenue20.1%above 10.0%passes11.91B USD ÷ 59.39B USD
Revenue growthRevenue ÷ Revenue a Year Before − 18.6%above 10.0%does not pass59.39B USD / 54.67B USD
Net cash(Cash − Total Debt) ÷ Market Cap4.2%above -30%passes(5.40B USD − 0 USD) ÷ 128.44B USD
Operating efficiencyOperating Income ÷ Gross Profit42.7%above 25.0%passes11.91B USD ÷ 27.88B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

59.64 USD

Enterprise value

156.73B USD

the provider's own figure

EV / EBITDA

14.40×

Price / book

6.99×

the provider's book

Price / earnings

20.62×

Return on equity

31.9%

the provider's figure, not this page's

Profit margin

18.3%

Revenue growth

0.5%

Analyst target, mean

71.71 USD

Analysts

4

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

Income statement (USD)2022202320242025

Revenue

64.11B57.26B54.67B59.39B

Gross profit

25.79B24.93B25.52B27.88B

Operating income

10.38B10.28B10.71B11.91B

EBITDA

operating income before depreciation and amortisation

13.95B11.89B11.19B13.10B

Pretax income

11.03B9.56B8.72B10.22B

Net income

8.16B7.19B5.98B11.13B

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

7.27B6.84B6.88B7.52B

R&D

968.96M1.05B1.03B—
Balance sheet, year end (USD)2022202320242025

Total assets

83.05B83.39B83.07B82.87B

Total liabilities

59.89B60.38B59.58B62.19B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

20.30B20.06B20.82B18.26B

Total debt

30.35B31.68B31.93B32.45B

Cash and equivalents

4.62B4.61B6.39B4.63B

Net PP&E

fixed assets after depreciation

11.49B11.86B12.16B10.57B

Working capital

current assets less current liabilities

-6.69B-6.21B-6.29B-5.40B
Cash flow (USD)2022202320242025

Operating cash flow

7.77B10.44B9.92B9.82B

Capital expenditure

paid out, so below zero

-1.82B-1.59B-1.68B-1.87B

Depreciation and amortisation

2.08B1.27B1.43B1.59B

Free cash flow

operating cash flow plus capital expenditure

5.95B8.85B8.23B7.95B